ATOR-1017, a 4-1BB antibody developed for tumor-directed immunotherapy of cancer

被引：0
|
作者：
Werchau, Doreen [1 ]
Rosen, Anna [2 ]
Eriksson, Mia [1 ]
Jarnum, Sofia [1 ]
Furebring, Christina [1 ]
Smith, Karin Enell [1 ]
机构：
[1] Alligator Biosci AB, Lund, Sweden
[2] Alligator Biosci, Lund, Sweden
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2019年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P608
引用
收藏
页数：1
相关论文
共 50 条
  • [21] 4-1BB immunotherapy: advances and hurdles
    Singh, Rohit
    Kim, Young-Ho
    Lee, Sang-Jin
    Eom, Hyeon-Seok
    Choi, Beom K.
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2024, 56 (01): : 32 - 39
  • [22] 4-1BB immunotherapy: advances and hurdles
    Rohit Singh
    Young-Ho Kim
    Sang-Jin Lee
    Hyeon-Seok Eom
    Beom K. Choi
    Experimental & Molecular Medicine, 2024, 56 : 32 - 39
  • [23] Optimization of 4-1BB antibody for cancer immunotherapy by balancing agonistic strength with FcγR affinity
    Xinyue Qi
    Fanlin Li
    Yi Wu
    Chen Cheng
    Ping Han
    Jieyi Wang
    Xuanming Yang
    Nature Communications, 10
  • [24] Optimization of 4-1BB antibody for cancer immunotherapy by balancing agonistic strength with FcγR affinity
    Qi, Xinyue
    Li, Fanlin
    Wu, Yi
    Cheng, Chen
    Han, Ping
    Wang, Jieyi
    Yang, Xuanming
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [25] Evaluation of a cancer immunotherapy with engineered arenavirus vectors and 4-1BB agonists in a preclinical tumor model
    Strauss, Judith
    Scheinost, Marilies
    Kleissner, Theresa
    Reckendorfer, Diana
    Pojar, Kimberly
    Habbeddine, Mohamed
    Ahmadi-Erber, Sarah
    Deutschmann, Daniela
    Schmidt, Sarah
    Raguz, Josipa
    Matushansky, Igor
    Lampert, Christoph
    Orlinger, Klaus K.
    Lauterbach, Henning
    CANCER RESEARCH, 2022, 82 (12)
  • [26] Claudin 18.2 X 4-1BB bispecific antibody induced potent tumor inhibition through tumor-specific 4-1BB activation
    Jiang, Wenqing
    Fang, Lei
    Wang, Zhengyi
    Guo, Taylor B.
    Park, Eunyoung
    Sung, Eunsil
    Jung, Jaeho
    CANCER RESEARCH, 2020, 80 (16)
  • [27] Immunotherapy targeting 4-1BB and its ligand
    Vinay, DS
    Kwon, BS
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2006, 83 (01) : 23 - 28
  • [28] Immunotherapy Targeting 4-1BB and Its Ligand
    Dass S. Vinay
    Byoung S. Kwon
    International Journal of Hematology, 2006, 83 : 23 - 28
  • [29] CLDN18.2 and 4-1BB bispecific antibody givastomig exerts antitumor activity through CLDN18.2-expressing tumor-directed T-cell activation
    Gao, Jing
    Wang, Zhengyi
    Jiang, Wenqing
    Zhang, Yanni
    Meng, Zhen
    Niu, Yanling
    Sheng, Zhen
    Chen, Chan
    Liu, Xuejun
    Chen, Xi
    Liu, Chanjuan
    Jia, Keren
    Zhang, Cheng
    Liao, Haiyan
    Jung, Jaeho
    Sung, Eunsil
    Chung, Hyejin
    Zhang, Jingwu Z.
    Zhu, Andrew X.
    Shen, Lin
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (06)
  • [30] Limited Cross-Linking of 4-1BB by 4-1BB Ligand and the Agonist Monoclonal Antibody Utomilumab
    Li, Yan
    Tan, Shuguang
    Zhang, Chang
    Chai, Yan
    He, Mengnan
    Zhang, Catherine W-H
    Wang, Qihui
    Tong, Zhou
    Liu, Kefang
    Lei, Yifan
    Liu, William J.
    Liu, Yingxia
    Tian, Zhigang
    Cao, Xuetao
    Yan, Jinghua
    Qi, Jianxun
    Tien, Po
    Gao, Shan
    Gao, George F.
    CELL REPORTS, 2018, 25 (04): : 909 - +
12345